Jun 10, 2020
International Atherosclerosis Society Issues Call to Action to Improve Lipid Management Based on Survey Results to Address Patients' Residual Risk
Mar 28, 2020
Novartis new analysis further showed durable and potent LDL-C reduction with inclisiran, an investigational first-in-class siRNA cholesterol-lowering treatment
Mar 18, 2020
Novartis announces NEJM publication of three pivotal trials showing durable and potent efficacy of inclisiran, an investigational first-in-class siRNA cholesterol-lowering therapy
Feb 06, 2020
Survivors in Canada are Taking Steps to Reduce the Risk of Another Heart Attack. But is it Enough?
Jan 02, 2020
Global Call To Action on Familial Hypercholesterolemia Aims to Improve Diagnosis and Treatment Worldwide
Dec 20, 2019
HealthWell Foundation Launches Fund to Provide Financial Assistance to Medicare Patients with Hypercholesterolemia
Nov 26, 2019
American Heart Association: Avoiding the Deadly Holiday Heart Attack
Sep 17, 2019
Familial Hypercholesterolemia Patients at High Risk for Cardiovascular Events Despite Treatment
Jul 23, 2019
Individuals Had More Heart Attacks and Strokes When Cholesterol-lowering Drug Prescription Was Rejected or Unfilled
Jul 18, 2019
HDL Cholesterol Kits Market to Witness an Opportunity Worth US$ 790 Mn by 2029-end | Future Market Insights
May 15, 2019
HDL Therapeutics Announces Positive Data From Registration Trial of PDS-2(TM) System in Homozygous Familial Hypercholesterolemia
Apr 11, 2019
FH Foundation Expands FIND FH® to Speed Diagnosis of Individuals with Homozygous Familial Hypercholesterolemia
Apr 11, 2019
FIND FH® Effectively Identified Individuals with Possible Familial Hypercholesterolemia (FH) in Electronic Health Records
Mar 20, 2019
Innovent Announces First Patient Dosed in a Phase IIa Clinical Study of IBI306, an Anti-PCSK9 Monoclonal Antibody
Mar 12, 2019
Amgen and Jay Leno Partner to Sound the Alarm on High Cholesterol and its Link to Heart Attack and Stroke in Patients Most at Risk
Feb 15, 2019
Statement from ABC President John M. Fontaine, MD, on the 2018 ACC/AHA Guideline on Management of Blood Cholesterol
Dec 04, 2018
Growing Prevalence of Cardiovascular Diseases Expected to Fuel Revenue Growth of the Point-of-Care Cholesterol Monitoring Device Market Through 2028 - Future Market Insights
Aug 22, 2018
Seq2Know Launches High Cholesterol Genetic Test
Jul 30, 2018
FH Foundation Announces Consensus Statement On Genetic Testing For Familial Hypercholesterolemia (FH)
Jul 20, 2018
Dr. Samuel Gidding Joins the FH Foundation as Chief Medical Officer